Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
48.92
+1.54 (3.25%)
At close: Dec 5, 2025, 4:00 PM EST
50.64
+1.72 (3.52%)
After-hours: Dec 5, 2025, 7:45 PM EST
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Rigel Pharmaceuticals stock have an average target of 43.2, with a low estimate of 24 and a high estimate of 57. The average target predicts a decrease of -11.69% from the current stock price of 48.92.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 5, 2025.
Analyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $23 → $42 | Hold → Strong Buy | Upgrades | $23 → $42 | -14.15% | Nov 5, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $32 → $38 | Hold | Maintains | $32 → $38 | -22.32% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +16.52% | Oct 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $23 → $32 | Hold | Maintains | $23 → $32 | -34.59% | Aug 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $20 → $23 | Hold | Maintains | $20 → $23 | -52.98% | May 7, 2025 |
Financial Forecast
Revenue This Year
296.76M
from 179.28M
Increased by 65.53%
Revenue Next Year
297.41M
from 296.76M
Increased by 0.22%
EPS This Year
6.69
from 0.99
Increased by 575.36%
EPS Next Year
4.40
from 6.69
Decreased by -34.23%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 310.4M | 374.0M | ||||
| Avg | 296.8M | 297.4M | ||||
| Low | 279.4M | 258.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 73.1% | 26.0% | ||||
| Avg | 65.5% | 0.2% | ||||
| Low | 55.9% | -12.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.95 | 5.45 | ||||
| Avg | 6.69 | 4.40 | ||||
| Low | 6.36 | 3.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 602.1% | -18.5% | ||||
| Avg | 575.4% | -34.2% | ||||
| Low | 542.4% | -47.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.